- Home
- POOL vs QGEN Comparison
POOL vs QGEN Comparison
Compare POOL & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | POOL | QGEN |
|---|---|---|
| Founded | 1993 | 1986 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 10.2B |
| IPO Year | 1995 | 1996 |
Fundamental Metrics
Financial Performance| Metric | POOL | QGEN |
|---|---|---|
| Price | $236.70 | $45.82 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $338.33 | $50.68 |
| AVG Volume (30 Days) | 863.4K | ★ 1.2M |
| Earning Date | 10-23-2025 | 11-04-2025 |
| Dividend Yield | 2.11% | ★ 3.30% |
| EPS Growth | N/A | ★ 331.20 |
| EPS | ★ 10.93 | 1.84 |
| Revenue | ★ $5,294,666,000.00 | $2,070,781,000.00 |
| Revenue This Year | $1.92 | $7.12 |
| Revenue Next Year | $3.55 | $6.13 |
| P/E Ratio | ★ $21.68 | $25.56 |
| Revenue Growth | N/A | ★ 5.32 |
| 52 Week Low | $229.63 | $37.63 |
| 52 Week High | $380.82 | $51.88 |
Technical Indicators
Market Signals| Indicator | POOL | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 33.60 | 45.97 |
| Support Level | $240.31 | $46.39 |
| Resistance Level | $251.73 | $47.48 |
| Average True Range (ATR) | 7.08 | 0.71 |
| MACD | 1.82 | 0.06 |
| Stochastic Oscillator | 29.28 | 44.12 |
Price Performance
Historical ComparisonAbout POOL Pool Corporation
Pool Corp distributes swimming pool supplies and related products. Its products include non-discretionary pool-maintenance products, like chemicals and replacement parts, as well as pool equipment, like packaged pools (kits to build swimming pools), cleaners, filters, heaters, pumps, and lights. Customers include pool builders and remodelers, independent retail stores, and pool repair and service companies.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).